Study supports tobacco link to ovarian cancer
(Medical Xpress)—Researchers from Curtin University's School of Public Health have contributed to a comprehensive international study examining risk factors for ovarian cancer.
Cancer
Sep 12, 2012 |
not rated yet |
0
|
Even with personalized assessments, many underestimate disease risks
People with a family history of certain diseases, including heart disease and diabetes, often underestimate their risk for developing them, even after completing a risk assessment and receiving personalized prevention messages, ...
Health
Sep 12, 2012 |
not rated yet |
0
Routine screening for ovarian cancer a failure: study
Routine screening for ovarian cancer is ineffective and at times can do more harm than good, a panel of cancer specialists has concluded.
Cancer
Sep 11, 2012 |
not rated yet |
0
U.S. panel rejects ovarian cancer screens for low-risk women
(HealthDay)—A leading U.S. government panel has recommended against ovarian cancer screening for women who are not at high risk for the disease.
Cancer
Sep 10, 2012 |
not rated yet |
0
Diagnostic chest radiation before 30 may increase breast cancer risk
Women carrying a mutation in the BRCA1- or BRCA2- genes (which control the suppression of breast and ovarian cancer) who have undergone diagnostic radiation to the chest before the age of 30 are more likely to develop breast ...
Cancer
Sep 06, 2012 |
5 / 5 (2) |
0
|
Ovarian cancer cells hijack surrounding tissues to enhance tumor growth
Tumor growth is dependent on interactions between cancer cells and adjacent normal tissue, or stroma. Stromal cells can stimulate the growth of tumor cells; however it is unclear if tumor cells can influence the stroma.
Cancer
Sep 04, 2012 |
5 / 5 (1) |
0
Team finds biological indicator of aggressive, recurrent forms of prostate cancer
(Medical Xpress)—In a study to decipher clues about how prostate cancer cells grow and become more aggressive, Johns Hopkins urologists have found that reduction of a specific protein is correlated with the aggressiveness ...
Cancer
Aug 27, 2012 |
5 / 5 (1) |
0
|
New nanoparticles that shut off cancer genes shrink tumors in mice
By sequencing cancer-cell genomes, scientists have discovered vast numbers of genes that are mutated, deleted or copied in cancer cells. This treasure trove is a boon for researchers seeking new drug targets, but it is nearly ...
Cancer
Aug 15, 2012 |
5 / 5 (7) |
2
|
Gene deletion drives more than a quarter of breast cancers
A new study shows that the lack of a certain gene occurs in almost 28 percent of human breast cancers, playing a role in some 60,000 breast cancer cases in the United States and 383,000 worldwide this year.
Genetics
Aug 15, 2012 |
4 / 5 (3) |
1
|
Mechanisms of acquired chemoresistance in ovarian cancer identified
The presence of multiple ovarian cancer genomes in an individual patient and the absence or downregulation of the gene LRP1B are associated with the development of chemoresistance in women with the high-grade serous cancer ...
Cancer
Aug 15, 2012 |
5 / 5 (1) |
0
Researchers investigate drug resistant ovarian cancer to improve clinical treatment
(Medical Xpress) -- A new study by TCD researchers investigates drug-resistant ovarian cancer cells. The findings which have been recently published in the international publication, PLoS One will increase ...
Cancer
Aug 09, 2012 |
not rated yet |
0
Benefit of PET and PET/CT in ovarian cancer is not proven
Due to the lack of studies, there is currently no proof that patients with ovarian cancer can benefit from positron emission tomography (PET) alone or in combination with computed tomography (CT). As regards diagnostic accuracy, ...
Cancer
Aug 08, 2012 |
not rated yet |
0
Using millions of years of cell evolution in the fight against cancer
As the medical community continues to make positive strides in personalized cancer therapy, scientists know some dead ends are unavoidable. Drugs that target specific genes in cancerous cells are effective, but not all proteins ...
Genetics
Aug 07, 2012 |
5 / 5 (3) |
1
|
New method provides fast, accurate, low cost analysis of BRCA gene mutations in breast cancer
Individuals with mutations in BRCA1 and BRCA2 genes have a significantly higher risk of developing breast and ovarian cancers. Families at risk have been seeking genetic testing and counseling based on their mutation carrier ...
Cancer
Aug 06, 2012 |
not rated yet |
0
Clinical trial for OVA1 blood test showing promising results for detecting ovarian cancer
(Medical Xpress) -- Researchers at Vermillion, a medical diagnostics company have announced that clinical trials for its OVA1® blood test diagnostic tool have shown promising results. The tool, part of Vermillion’s ...
Cancer
Jul 31, 2012 |
not rated yet |
0
|
